Learning Objectives

Joining forces and sharing experiences in the development of innovative health care products 


Bridging gaps in the understanding of interdependencies between drug, device, IVD components and combination products


Accessing new technologies in drug delivery


Minimising risk to investments


Understanding specific regulatory affairs and market access aspects affecting the development of innovative products


Session Topics

Innovation and trends in developing new solutions for medical needs


Technological developments for combination products


Approval and conduct of clinical studies


Regulatory frameworks applying at the interface of drugs, devices and IVDs


Intellectual property from the perspective of increasing transparency requirements


Market access and pricing


Be part of the first International Medtech & Pharma Platform entitled "Innovation at the Interface", that brings together professionals from the Medtech and Pharma industry, as well as regulators.

Benefit from interdisciplinary discussions of technological, regulatory and market access aspects.

Our two-day conference includes six thematic sessions with 18 highly decorated speakers, a networking dinner, a table top exhibition and lots of time for individual discussions.

We are looking forward to welcoming you to the first International Medtech & Pharma Platform entitled "Innovation at the Interface" being held on October, 30-31 2014 at the Swissôtel Oerlikon in Zurich.


Shayesteh Fürst-Ladani
Managing Director
SFL Regulatory Affairs

Peter Biedermann
Managing Director
Medical Cluster